S
Shanghai Pinfeng Medical Technology
Offers intelligent testing and precise diagnostic solutions to global in vitro diagnostic markets
About Shanghai Pinfeng Medical Technology
Shanghai Pinfeng Medical Technology, established in 2020, is a key player in the in-vitro diagnostics (IVD) sector, concentrating on the development of intelligent laboratory solutions. The company was founded by Ding Wei, a veteran with over two decades of experience in the global IVD field, who previously held executive positions at bioMérieux and Kehua Bio-engineering. His extensive background in product development, strategic acquisitions, and sales management within the diagnostics market underpins the company's direction.
Pinfeng Medical operates in the medical technology market, specifically targeting clinical laboratories in hospitals and other medical institutions. The firm's business model revolves around providing comprehensive solutions that encompass instruments, reagents, and software, aiming to capture the entire workflow of a clinical laboratory. This strategy addresses the market's shift towards greater automation and integrated information management. Revenue is generated through the sale of these integrated systems and associated consumables. The company is positioning itself to address the growing demand for efficiency and accuracy in clinical diagnostics, driven by policy support for 'Smart Hospitals' and payment reforms in China.
The core of Pinfeng's offering is the "i-Lab unattended laboratory," a concept designed to achieve complete automation and intelligent management from sample receipt to final result. This solution integrates robotics for sample handling and transport, advanced diagnostic instruments, and a sophisticated laboratory information management system to create a seamless workflow. Key products include the PINNACLES i-Lab, automated assembly lines like the S-LAS series, and a range of diagnostic instruments for immunoassay, clinical chemistry, and molecular diagnostics. A significant achievement is the partnership with the international firm INPECO to localize the production of the advanced FlexLab X automated system, enhancing its ability to serve the Chinese market with customized, high-throughput solutions.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 22.0/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotechnology, Biotech and Pharma, DT and LS, science-based
- Client focus
- B2B
- Investment activity
- 1 company, latest Jun 2024
- Capital deployed
- $0
- Preferred round
- SERIES A
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Aug 2023 | $28M | $110M | Oriental Fortune Capital · Industrial Securities Capital · Yushan Partners · Tsing Song Capital | ↗ |
| SERIES AOther financing | Oct 2021 | $41M | $165M | Vertex Ventures China | ↗ |
Growth signals
Latest recorded traffic for Shanghai Pinfeng Medical Technology is 590 monthly website visits, up 883.3% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Shanghai Pinfeng Medical Technology in its local ecosystem
The Shanghai Pinfeng Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Vertex Ventures China
Oriental Fortune Capital
Industrial Securities Capital
Yushan Partners
Tsing Song Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Shanghai Pinfeng Medical Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Shanghai Pinfeng Medical Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








